Respiree raises Series A funding
Respiree, a Singapore-founded health tech firm, has raised USD 11.6 million in a Series A funding round co-led by We Venture Capital and ClavystBio, with participation from Adaptive Capital Partners, Mayo Clinic’s Mayo Foundation, and existing investors including Greenwillow Capital Management, Seeds Capital, and She1K.